Literature DB >> 18559672

Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome.

Taizo Wada1, Masahiro Yasui, Tomoko Toma, Yuko Nakayama, Mika Nishida, Masaki Shimizu, Michiko Okajima, Yoshihito Kasahara, Shoichi Koizumi, Masami Inoue, Keisei Kawa, Akihiro Yachie.   

Abstract

X-linked severe combined immunodeficiency (XSCID) is caused by mutations of the common gamma chain (gammac) and usually characterized by the absence of T and natural killer (NK) cells. Here, we report an atypical case of XSCID presenting with autologous T and NK cells and Omenn syndrome-like manifestations. The patient carried a splice-site mutation (IVS1+5G>A) that caused most of the mRNA to be incorrectly spliced but produced normally spliced transcript in lesser amount, leading to residual gammac expression and development of T and NK cells. The skin biopsy specimen showed massive infiltration of revertant T cells. Those T cells were found to have a second-site mutation and result in complete restoration of correct splicing. These findings suggest that the clinical spectrum of XSCID is quite broad and includes atypical cases mimicking Omenn syndrome, and highlight the importance of revertant mosaicism as a possible cause for variable phenotypic expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559672     DOI: 10.1182/blood-2008-04-149708

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

2.  Mutations to the rescue.

Authors:  Mike May
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

3.  A leaky mutation in CD3D differentially affects αβ and γδ T cells and leads to a Tαβ-Tγδ+B+NK+ human SCID.

Authors:  Juana Gil; Elena M Busto; Beatriz Garcillán; Carmen Chean; Maria Cruz García-Rodríguez; Andrea Díaz-Alderete; Joaquín Navarro; Jesús Reiné; Angeles Mencía; Dolores Gurbindo; Cristina Beléndez; Isabel Gordillo; Marlena Duchniewicz; Kerstin Höhne; Félix García-Sánchez; Eduardo Fernández-Cruz; Eduardo López-Granados; Wolfgang W A Schamel; Miguel A Moreno-Pelayo; María J Recio; José R Regueiro
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

4.  Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.

Authors:  Federica Cattaneo; Mike Recher; Stefania Masneri; Sachin N Baxi; Claudia Fiorini; Francesca Antonelli; Christian A Wysocki; Jose G Calderon; Hermann Eibel; Angela R Smith; Francisco A Bonilla; Erdyni Tsitsikov; Silvia Giliani; Luigi D Notarangelo; Sung-Yun Pai
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

5.  A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.

Authors:  Wenjun Mou; Jianxin He; Xi Chen; Hui Zhang; Xiaoya Ren; Xunyao Wu; Xin Ni; Baoping Xu; Jingang Gui
Journal:  Immunogenetics       Date:  2016-08-26       Impact factor: 2.846

6.  Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency.

Authors:  Sebastian Fuchs; Anne Rensing-Ehl; Ulrich Pannicke; Myriam R Lorenz; Paul Fisch; Yogesh Jeelall; Jan Rohr; Carsten Speckmann; Thomas Vraetz; Susan Farmand; Annette Schmitt-Graeff; Marcus Krüger; Brigitte Strahm; Philipp Henneke; Anselm Enders; Keisuke Horikawa; Christopher Goodnow; Klaus Schwarz; Stephan Ehl
Journal:  Blood       Date:  2015-08-19       Impact factor: 22.113

7.  Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.

Authors:  Yusuke Okuno; Akihiro Hoshino; Hideki Muramatsu; Nozomu Kawashima; Xinan Wang; Kenichi Yoshida; Taizo Wada; Masaharu Gunji; Tomoko Toma; Tamaki Kato; Yuichi Shiraishi; Atsuko Iwata; Toshinori Hori; Toshiyuki Kitoh; Kenichi Chiba; Hiroko Tanaka; Masashi Sanada; Yoshiyuki Takahashi; Shigeaki Nonoyama; Masafumi Ito; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-09-26       Impact factor: 8.317

8.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

Review 9.  Partial defects of T-cell development associated with poor T-cell function.

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-03-05       Impact factor: 10.793

10.  Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.

Authors:  Osama Alsmadi; Abdulaziz Al-Ghonaium; Saleh Al-Muhsen; Rand Arnaout; Hasan Al-Dhekri; Bandar Al-Saud; Fadi Al-Kayal; Haya Al-Saud; Hamoud Al-Mousa
Journal:  BMC Med Genet       Date:  2009-11-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.